
Deccan Health Care Ltd Upgraded to Sell on Technical Improvements and Valuation Appeal
2026-04-30 08:16:50Deccan Health Care Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 29 Apr 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The healthcare services micro-cap, with a market capitalisation classified as micro-cap and a current Mojo Score of 34.0, has demonstrated mixed signals across quality, valuation, financial trends, and technical parameters, prompting a nuanced reassessment by analysts.
Read MoreDeccan Health Care Ltd Gains 23.59%: 2 Key Factors Driving the Surge
2026-04-11 12:03:37Key Events This Week 6 Apr: Week opens at Rs.9.07 7 Apr: Mojo Grade downgraded to Strong Sell; stock surges 9.92% to Rs.9.97 8 Apr: Valuation grade shifts from very attractive to attractive; stock rises 4.91% to Rs.10.46 9 Apr: Continued gains with 4.97% rise to Rs.10.98 10 Apr: Week closes at Rs.11.21, up 2.09% on the day Week OpenRs.9.07 ...
Read More
Deccan Health Care Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Market Challenges
2026-04-08 08:00:57Deccan Health Care Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite ongoing operational challenges and a micro-cap status. With a current price of ₹9.97 and a significant day gain of 9.92%, the healthcare services company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a compelling entry point relative to its peers and historical benchmarks.
Read More
Markets Rise, But Deccan Health Care Ltd Slides to All-Time Low Amid Stock-Specific Sell-Off
2026-03-30 09:38:23Despite a broadly positive market environment, Deccan Health Care Ltd has continued its downward trajectory, hitting an all-time low of ₹7.48 on 30 Mar 2026 after a prolonged period of decline.
Read MoreDeccan Health Care Ltd Falls 32.84%: 5 Key Factors Behind the Steep Decline
2026-03-28 12:00:06Key Events This Week 23 Mar: Stock hits 52-week and all-time low at Rs.9.20 24 Mar: Further decline to Rs.8.85 amid valuation upgrade 25 Mar: New 52-week low of Rs.8.30 despite sector gains 27 Mar: Week closes at Rs.7.32, marking a 9-session losing streak Week OpenRs.10.90 Week CloseRs.7.32</di...
Read More
Deccan Health Care Ltd Extends Losing Streak to 9 Sessions, Touches All-Time Low
2026-03-27 09:47:22For the ninth consecutive session, Deccan Health Care Ltd has continued its downward trajectory, hitting a fresh all-time low of Rs 7.61 on 27 Mar 2026. This persistent decline has resulted in a staggering 40.31% loss over just over a week, underscoring the severity of the stock's current position.
Read More
Deccan Health Care Ltd Extends Losing Streak to Seven Sessions, Hits All-Time Low
2026-03-25 12:47:18
Deccan Health Care Ltd Valuation Shifts to Very Attractive Amid Steep Price Decline
2026-03-24 08:02:05Deccan Health Care Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating despite a sharp decline in its share price. The healthcare services micro-cap, currently trading at ₹9.20, has seen its price-to-earnings (P/E) and price-to-book value (P/BV) ratios compress well below industry and peer averages, signalling a potential value opportunity amid ongoing market pressures.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
01-Jun-2026 | Source : BSEIntimation of Newspaper Publication of Financial Results for the quarter and year ended March 31 2026.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
30-May-2026 | Source : BSEAnnual Results for the FY 2025-26 and Corporate Update
Board Meeting Outcome for Outcome Of Board Meeting- To Considered And Approved The Standalone And Consolidated Audited Financial Results Of The Company For The Year Ended On March 31 2026 Along With Auditors Report With Unmodified Opinion.
30-May-2026 | Source : BSEBoard of Directors of the Company at its meeting held today i.e. Saturday 30th May 2026 which was commenced at 3:00 PM Via Video Conferencing has inter alia considered and approved the following: 1. The Standalone and Consolidated Audited Financial Results of the Company for the year ended on March 31 2026 along with Auditors Report with Unmodified opinion. 2. Declaration by the Company pursuant to Regulation 33 (3)(d) of the SEBI (LODR) Regulations 2015 is enclosed herewith.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
